Table 3.
Distribution among all quit attempters |
Model A—among Rx SSM users |
Model B—among SSM users |
Model G—varenicline versus no SSM use |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n= 274 (82% used varenicline) | n = 481 (39% used varenicline) | n = 779 (28% used varenicline) | |||||||||||
Correlates | % | n | % varenicline | OR | P | n | % varenicline | OR | P | n | %varenicline | OR | P |
Sex | |||||||||||||
Female | 59 | 163 | 85 | Referent | 297 | 40 | Referent | 450 | 30 | Referent | |||
Male | 41 | 111 | 78 | 0.51 | 0.047 | 184 | 38 | 0.84 | 0.369 | 329 | 25 | 0.80 | 0.189 |
Age group (years) | |||||||||||||
18–24 | 4 | 3 | 75 | Referent | 10 | 19 | Referent | 35 | 8 | Referent | |||
25–39 | 16 | 48 | 77 | 1.43 | 0.805 | 70 | 44 | 3.03 | 0.179 | 124 | 26 | 5.61 | 0.025 |
40–54 | 41 | 112 | 82 | 1.64 | 0.731 | 214 | 36 | 2.02 | 0.386 | 314 | 28 | 5.01 | 0.032 |
55+ | 39 | 111 | 84 | 2.96 | 0.454 | 187 | 42 | 3.34 | 0.138 | 306 | 30 | 5.46 | 0.024 |
Race/ethnicity | |||||||||||||
Other | 17 | 25 | 80 | Referent | 50 | 32 | Referent | 131 | 15 | Referent | |||
Non-Hispanic white | 83 | 249 | 82 | 1.22 | 0.683 | 431 | 40 | 1.59 | 0.140 | 648 | 30 | 2.33 | 0.002 |
Education | |||||||||||||
Low | 33 | 88 | 82 | Referent | 185 | 35 | Referent | 325 | 22 | Referent | |||
Moderate | 36 | 123 | 80 | 0.89 | 0.747 | 204 | 39 | 1.19 | 0.407 | 286 | 32 | 1.76 | 0.002 |
High | 30 | 64 | 87 | 1.59 | 0.312 | 95 | 46 | 1.59 | 0.076 | 171 | 31 | 1.50 | 0.071 |
Income | |||||||||||||
Low | 42 | 70 | 75 | Referent | 153 | 29 | Referent | 245 | 21 | Referent | |||
Moderate | 36 | 98 | 84 | 1.93 | 0.082 | 166 | 42 | 1.57 | 0.040 | 260 | 31 | 1.54 | 0.034 |
High | 22 | 80 | 87 | 2.67 | 0.025 | 130 | 46 | 2.01 | 0.006 | 218 | 31 | 1.85 | 0.005 |
HSIa | |||||||||||||
0–1 | 27 | 51 | 78 | Referent | 100 | 35 | Referent | 226 | 16 | Referent | |||
2–3 | 47 | 138 | 80 | 1.22 | 0.616 | 256 | 37 | 1.09 | 0.729 | 393 | 28 | 1.67 | 0.015 |
4–6 | 25 | 102 | 87 | 2.36 | 0.054 | 167 | 44 | 1.66 | 0.050 | 226 | 39 | 2.40 | 0.001 |
Ever used any SSMb | |||||||||||||
No | 43 | 64 | 81 | Referent | 119 | 39 | Referent | 344 | 13 | Referent | |||
Yes | 57 | 221 | 82 | 0.97 | 0.943 | 382 | 39 | 1.07 | 0.755 | 452 | 38 | 3.29 | <0.001 |
Analyses included data from waves 6℃8 and were adjusted for sex, age group, race/ethnicity, education, income, heavy smoking index (HSI) and survey wave; generalized estimating equation (GEE) modelling was used to account for repeated observations of the same respondents over time; ns indicate number of unique individuals within cells; percentages consider multiple observations per individual.
Assessed at wave preceding evaluation of medication use;
Assessed prior to evaluation of medication use by combining life-time use with annual use. OR = odds ratio.